The EPO published Bard Peripheral Vascular's patent application for a low-profile transitionable access port (EP4340926A1) on March 25, 2026. The patent covers an implantable medical device for vascular access, classified under A61M 39/02 and A61M 39/04, with designations extending to all EU member states plus Switzerland, Norway, and other EPC contracting states.

This is a routine patent publication announcement with no compliance requirements or deadlines. Medical device manufacturers and competitors should review the patent claims for freedom-to-operate analysis and potential licensing considerations. No immediate action is required by regulated entities.